Literature DB >> 11133764

JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.

B Sporri1, P E Kovanen, A Sasaki, A Yoshimura, W J Leonard.   

Abstract

JAB/suppressor of cytokine signaling 1 (SOCS1) STAT-induced STAT inhibitor-1 (SSI-1) (JAB/SOCS1/SSI-1) is an SH2-domain-containing protein that is induced by and negatively regulates signaling by a number of cytokines including interleukin-4 (IL-4), IL-6, interferon (IFN)-gamma, prolactin, growth hormone, and erythropoietin. The role of JAB/SOCS1/SSI-1 in IL-2 signaling has been analyzed. JAB/SOCS1/SSI-1 is strongly induced by IL-2 in peripheral blood T cells, and JAB/SOCS1/SSI-1 overexpression strongly inhibits IL-2-induced signal transducer and activator of transcription-5 (Stat5) phosphorylation and transcriptional activity. In cotransfection experiments, JAB/SOCS1/SSI-1 associates with both Jak1 and Jak3; however, JAB/SOCS1/SSI-1 had a greater effect on Jak1 tyrosine phosphorylation and kinase activity. JAB/SOCS1/SSI-1 also interacts with IL-2Rbeta, and this interaction requires the A region (residues 313-382) of IL-2Rbeta. However, this interaction was not essential for the inhibitory action of JAB. Thus, JAB/SOCS1/SSI-1 is an IL-2-induced inhibitor of IL-2 signaling that functions by inhibiting Jak kinase activity. This suggests an important role for JAB/SOCS1/SSI-1 in regulating T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11133764     DOI: 10.1182/blood.v97.1.221

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

Review 1.  The central role of SOCS-3 in integrating the neuro-immunoendocrine interface.

Authors:  C J Auernhammer; S Melmed
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

2.  A MyD88-JAK1-STAT1 complex directly induces SOCS-1 expression in macrophages infected with Group A Streptococcus.

Authors:  Jinghua Wu; Cuiqing Ma; Haixin Wang; Shuhui Wu; Gao Xue; Xinli Shi; Zhang Song; Lin Wei
Journal:  Cell Mol Immunol       Date:  2014-11-17       Impact factor: 11.530

3.  Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.

Authors:  Steven J Bensinger; Patrick T Walsh; Jidong Zhang; Martin Carroll; Ramon Parsons; Jeffrey C Rathmell; Craig B Thompson; Matthew A Burchill; Michael A Farrar; Laurence A Turka
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

Review 4.  Therapeutic targeting of Janus kinases.

Authors:  Marko Pesu; Arian Laurence; Nandini Kishore; Samuel H Zwillich; Gary Chan; John J O'Shea
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

5.  Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes.

Authors:  Hongwei Qin; Sandrine A Niyongere; Sun Jung Lee; Brandi J Baker; Etty N Benveniste
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

Review 6.  Roles of TRAF3 in T cells: many surprises.

Authors:  Zuoan Yi; Alicia M Wallis; Gail A Bishop
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 7.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

Review 8.  SOCS1 and its Potential Clinical Role in Tumor.

Authors:  Jie Ying; Xiaoyan Qiu; Yu Lu; Miaomiao Zhang
Journal:  Pathol Oncol Res       Date:  2019-02-13       Impact factor: 3.201

9.  SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication.

Authors:  Run-Xuan Shao; Leiliang Zhang; Zhi Hong; Kaku Goto; Du Cheng; Wen-Chi Chen; Nikolaus Jilg; Kattareeya Kumthip; Dahlene N Fusco; Lee F Peng; Raymond T Chung
Journal:  Antiviral Res       Date:  2012-12-10       Impact factor: 5.970

10.  Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.

Authors:  Feng-Ju Huang; Patricia S Steeg; Janet E Price; Wen-Tai Chiu; Ping-Chieh Chou; Keping Xie; Raymond Sawaya; Suyun Huang
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.